Table 1 Clinical and virologic characteristics of HCC patients in NUC group and non-NUCl group
NUC group n = 33(%) | Non-NUC group n = 43(%) | P value | |
|---|---|---|---|
Liver area pain | 12(36.36%) | 34(79.07%) | < 0.05 |
Fatigue | 13(39.39%) | 22(51.16%) | 0.308 |
Vomit | 2(6.06%) | 2(4.65%) | 0.785 |
Appetite loss | 10(30.30%) | 30(70.27%) | < 0.05 |
TBIL (umol/L) | 31.39 ± 5.96 | 43.37 ± 11.37 | 0.370 |
ALB(g/L) | 35.76 ± 1.26 | 35.39 ± 0.94 | 0.475 |
HBeAg negative | 32(96.97%) | 41(95.35%) | 0.719 |
HBV-DNA undetectable | 21(63.64%) | 6(11.63%) | < 0.05 |
ALT< 40 U/L | 25(75.76%) | 11(25.58%) | < 0.05 |
AFP (ng/ml) < 14.65 | 13(39.39%) | 11(25.58%) | 0.199 |